Legacy Pharma

George Town, Grand Cayman
Legacy Pharma is engaged in distributing prescription pharmaceutical products.

About Legacy Pharma

Legacy Pharma is a Healthcare company based in George Town, Grand Cayman. Legacy Pharma is engaged in distributing prescription pharmaceutical products. It operates on a Reseller / Distribution model. Legacy Pharma has completed 1 acquisition, including InterMune. Legacy Pharma offers products and services including Betapace and Zanaflex. Its focus areas include Pharmaceuticals and Prescription Drugs.

Company details

Legacy Pharma Inc. SEZC is involved in the distribution of established prescription pharmaceutical products. The company focuses on ensuring that in-demand brands remain accessible to patients who require them. Operations are conducted in the healthcare sector, specifically targeting the availability of critical medications for various conditions. Solutions are provided through a portfolio of products addressing arrhythmias, spasticity, and other medical needs.

  • Headquarters George Town, Grand Cayman
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website legacypharmainc.com
Key Metrics

Products & Services of Legacy Pharma

Legacy Pharma offers a comprehensive portfolio of products and services, including Betapace and Zanaflex.

Betapace
Pharmaceuticals

Betapace is used to treat life-threatening ventricular arrhythmias.

Zanaflex
Pharmaceuticals

Zanaflex is used to manage spasticity in patients.

People of Legacy Pharma

2 people are tracked at Legacy Pharma (2 in leadership).

NameRoleGroup
Adeel Ahmad
Chief Financial OfficerLeadership
Mark Thompson
CEOLeadership
Premium access

Complete people profiles for Legacy Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Legacy Pharma

Legacy Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include InterMune.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Therapies in pulmonology and orphan fibrotic diseases.
intermune.comBrisbane, United States1998Feb 2025β€’β€’β€’β€’
Premium access

Complete acquisition details for Legacy Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Legacy Pharma

Legacy Pharma Inc. SEZC is involved in the distribution of established prescription pharmaceutical products. The company focuses on ensuring that in-demand brands remain accessible to patients who require them. Operations are conducted in the healthcare sector, specifically targeting the availability of critical medications for various conditions. Solutions are provided through a portfolio of products addressing arrhythmias, spasticity, and other medical needs.

Legacy Pharma offers Betapace and Zanaflex.

Legacy Pharma has made 1 acquisition, including InterMune.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available